Hiroshi Yamanaka

Chiba, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

A retrospective comparative analysis of the clinical response to clozapine between patients with early and late treatment-resistant schizophrenia.

A retrospective comparative analysis of the clinical response to clozapine between patients with early and late treatment-resistant schizophrenia.

Journal: Journal of psychiatric research

Published: February 20, 2026

The effects of cumulative antipsychotic dose on brain structures in patients with schizophrenia: Observational study of multiple CT scans over a long-term clinical course.

The effects of cumulative antipsychotic dose on brain structures in patients with schizophrenia: Observational study of multiple CT scans over a long-term clinical course.

Journal: Psychiatry research. Neuroimaging

Published: May 31, 2021

The effectiveness of very slow switching to aripiprazole in schizophrenia patients with dopamine supersensitivity psychosis: a case series from an open study.

The effectiveness of very slow switching to aripiprazole in schizophrenia patients with dopamine supersensitivity psychosis: a case series from an open study.

Journal: International clinical psychopharmacology

Published: September 02, 2020

First-episode psychosis in treatment-resistant schizophrenia: a cross-sectional study of a long-term follow-up cohort.

First-episode psychosis in treatment-resistant schizophrenia: a cross-sectional study of a long-term follow-up cohort.

Journal: BMC psychiatry

Published: May 15, 2018

Identifying improvable employment-related factors in schizophrenia patients.

Identifying improvable employment-related factors in schizophrenia patients.

Journal: Psychiatry research

Published: July 25, 2017

Risperidone long-acting injectable in the treatment of treatment-resistant schizophrenia with dopamine supersensitivity psychosis: Results of a 2-year prospective study, including an additional 1-year follow-up.

Risperidone long-acting injectable in the treatment of treatment-resistant schizophrenia with dopamine supersensitivity psychosis: Results of a 2-year prospective study, including an additional 1-year follow-up.

Journal: Journal of psychopharmacology (Oxford, England)

Published: July 03, 2016

Impact of dopamine supersensitivity psychosis in treatment-resistant schizophrenia: An analysis of multi-factors predicting long-term prognosis.

Impact of dopamine supersensitivity psychosis in treatment-resistant schizophrenia: An analysis of multi-factors predicting long-term prognosis.

Journal: Schizophrenia research

Published: July 21, 2015

Dopamine supersensitivity psychosis as a pivotal factor in treatment-resistant schizophrenia.

Dopamine supersensitivity psychosis as a pivotal factor in treatment-resistant schizophrenia.

Journal: Psychiatry research

Published: September 07, 2014

A prospective comparative study of risperidone long-acting injectable for treatment-resistant schizophrenia with dopamine supersensitivity psychosis.

A prospective comparative study of risperidone long-acting injectable for treatment-resistant schizophrenia with dopamine supersensitivity psychosis.

Journal: Schizophrenia research

Published: September 24, 2013

Effectiveness of long-acting injectable risperidone for patients with treatment refractory schizophrenia

Effectiveness of long-acting injectable risperidone for patients with treatment refractory schizophrenia

Journal: Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology

Published: April 01, 2013

Onset Pattern and Long-Term Prognosis in Schizophrenia: 10-Year Longitudinal Follow-Up Study.

Onset Pattern and Long-Term Prognosis in Schizophrenia: 10-Year Longitudinal Follow-Up Study.

Journal: PloS one

Published: February 22, 2013

Showing 1-11 of 11

Last Updated: 09/26/2026